Endocrinology & Diabetes

US News - Stanford Medicine Children's HealthThe endocrine system is a complex collection of hormone-producing glands that control basic body functions such as metabolism, growth and sexual development. The pediatric endocrinology team at Stanford Medicine Children’s Health is ranked in the top 10 in Diabetes & Endocrinology by U.S. News & World Report and treats children with endocrine disorders at convenient locations throughout the Bay Area.

Diagnosis and management of endocrine and metabolic disorders

We diagnose and manage children with many different endocrine and metabolic disorders, including:

YouTube Video
YouTube Play/Stop Button

The "artificial pancreas" is changing the game for type 1 diabetes patients

At 19 months old, Jamie was diagnosed with Type 1 diabetes. For the next 10 years, her parents would wake up every three hours during the night to check her blood glucose level. 

Learn more about Jamie’s story >

Research updates

A new pilot study published in April 2022 in JCEM shows children with new-onset Type 1 diabetes benefited from the Stanford Medicine Children's Health-developed 4T Program: Teamwork, Targets, Technology, and Tight Control. Results showed that children who participated in the program significantly reduced HbA1c 12-month post diagnosis. Learn more >

 

A March 2022 study found bioengineered cone snail venom-human hybrid molecules may provide faster-acting, blood sugar level reducing insulin. Testing in animal models and clinical trials in people are still needed, however, the discovery of this hybrid-insulin could mean patients with diabetes would no longer need to track what they eat or plan insulin doses prior to meals. Learn more > 

 

A November 2021 study found that setting children and teens up with the latest treatment devices shortly after a Type 1 Diabetes diagnosis benefits their health a year later. Children and teens who learned to use continuous glucose monitors (CGMs) within one month of their diabetes diagnosis had healthier blood sugar levels than patients who weren’t given the monitors near the time of diagnosis. Learn more >

 

An August 2021 review of diabetes telehealth visits occurring before COVID-19, during shelter-in-place orders, and during the reopening period indicates pandemic-related telehealth expansion increased participation of patients with public insurance and those who did not speak English. The finding suggests that prioritizing inclusive telehealth workflows can reduce disparities in access to care for diabetes patients.

 

A July 2021 study led by Stanford Children’s Health endocrinologists in collaboration with colleagues from the University of Florida, found patients with type 1 diabetes in vulnerable communities often face significant disparities in care. As part of project ECHO Diabetes, adult patients from rural Northern California and Florida were interviewed about challenges they encountered in trying to manage their disease. Learn more >

 

For clinical questions, please contact the LPCH Diabetes Educators at (650) 498-7353 or diabetes@stanfordchildrens.org.

For research questions, please contact the Stanford Diabetes Research Team at diabetesresearch@stanford.edu.

Please visit dped.stanford.edu for more information about clinical research.